Find a Tender
complete
Official procurement procedure
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
46.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Feb 2024, 12:50 GMT | Last source update26 Feb 2024, 12:50 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-040e74 | ||
What is being bought
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
What changed
From the official release history
- Status changed to complete
26 Feb 2024, 12:50 GMT - Official notice release published
26 Feb 2024, 12:50 GMT - tender value changed
24 Oct 2023, 11:06 BST - Status changed to published status
24 Oct 2023, 11:06 BST - Official notice release published
24 Oct 2023, 11:06 BST - Submission deadline changed to published date
24 Oct 2023, 11:06 BST - Published value updated to £1,833,333,000
24 Oct 2023, 10:12 BST - Status changed to active
24 Oct 2023, 10:12 BST - Official notice release published
24 Oct 2023, 10:12 BST - Submission deadline changed to 24 Nov 2023, 13:00 GMT
24 Oct 2023, 10:12 BST - Buyer information updated
24 Oct 2023, 10:12 BST
Lots and requirements (4)
Published by the contracting authority
- Lot 1 · #1CM/PHR/22/5678/01cancelledPublished valueNot publishedCM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2CM/PHR/22/5678/02cancelledPublished valueNot publishedNHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3CM/PHR/22/5678/03cancelledPublished valueNot publishedCM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4CM/PHR/22/5678/04cancelledPublished valueNot publishedCM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Feb 2024, 12:50 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1 - Contract active
Signed 26 Jan 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards Celltrion Healthcare United Kingdom Limited Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Ipsen Not published · Not published · active Napp Pharmaceuticals Ltd Not published · Not published · active CST Pharma Limited Not published · Not published · active Orifarm UK Not published · Not published · active Teva UK Limited Not published · Not published · active Novo Nordisk Not published · Not published · active Novartis Pharmaceuticals UK Ltd Not published · Not published · active Biogen Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active GlaxoSmithKline UK Limited Not published · Not published · active Celltrion Healthcare United Kingdom Limited Not published · Not published · active Merck Sharpe and Dohme (UK) Limited Not published · Not published · active Accord-UK Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Pfizer Ltd Not published · Not published · active Aventis Pharma ltd t/a Sanofi Not published · Not published · active Sun Pharma UK Ltd Not published · Not published · active Sobi (Swedish Orphan Biovitrum Ltd) Not published · Not published · active Neon Healthcare Ltd Not published · Not published · active Galapagos Biotech Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active AstraZeneca Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Almirall Not published · Not published · active Orifarm UK Not published · Not published · active Teva UK Limited Not published · Not published · active Novartis Pharmaceuticals UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Gedeon Richter UK Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Vifor Pharma UK Ltd Not published · Not published · active Chugai Pharma UK Ltd Not published · Not published · active Abbvie Ltd Not published · Not published · active Merck Serono Limited Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Bayer Plc Not published · Not published · active Roche Products Ltd Not published · Not published · active Ipsen Not published · Not published · active Merz Not published · Not published · active Napp Pharmaceuticals Ltd Not published · Not published · active Pharmacosmos UK Ltd Not published · Not published · active |
Contracts CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A £1 · signed 26 Jan 2024, 00:00 GMT · active |
Bid statistics bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) bids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) electronicBids: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) foreignBidsFromEU: 21 (lot 1) |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-3022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published